Molnupiravir

This makes it one of the cheapest antiviral coronavirus therapies available. A full treatment of Molnupiravir, an antiviral drug approved by the Drug Controller General of India (DCGI) for emergency use, will cost Rs 1,399 for the…

The drug is developed by MSD and Ridgeback Biotherapeutics. A full treatment of Molnupiravir, an antiviral drug approved by the Drug Controller General of India for emergency use, will likely cost between Rs 2,000 and Rs 3,000. The…

Molnupiravir, developed by Merck & Co. and Ridgeback Biotherapeutics LP, the first anti-viral Covid-19 pill, was approved by the Indian drug regulator on Tuesday. Due to the Omicron variety spreads, the Central Drugs Standard…